Clinical and Histopathologic Spectrum of Primary Nonfunction in Renal Allografts.

Authors

Tiffany N Caza, Hamza Ijaz, Jason J Paris, Christopher P Larsen

Published in

Kidney international reports. Volume 11. Issue 10. Pages 106699. Epub Jul 14, 2026.

Abstract

Primary nonfunction (PNF) is a serious complication of renal allografts, occurring in a subset of patients with delayed graft function (DGF) who never obtain freedom from dialysis. Prior studies have examined donor and recipient variables implicated in DGF and PNF; however, data on the underlying kidney pathology are largely lacking.
Data from the Scientific Registry of Transplant Recipients (SRTR) was merged with biopsy records, and patients with a history of DGF or PNF were identified. We compared all patients with PNF (n = 61) and DGF with a biopsy within 30 days posttransplantation (n = 714) to identify donor, recipient, and histologic variables associated with PNF. Student t tests and Fisher exact tests were used for evaluation of continuous and categorical variables, respectively. Binary logistic regression was performed for more stringent assessment of PNF predictors.
PNF was significantly associated with increased donor age (P = 0.002) and terminal creatinine > 1.5 mg/dl (P = 0.005). There was no impact of recipient age, sex, race, or disease comorbidities (hypertension, diabetes, or obesity). Kidney pathology of allograft biopsies showed an increase in diagnoses of cortical necrosis (P < 0.0001), arterionephrosclerosis (P = 0.0002), oxalate nephropathy (P = 0.03), pyelonephritis (P = 0.009), and antibody-mediated rejection (ABMR) (P = 0.0008) compared with patients with DGF who did not progress to PNF.
In patients with DGF progressing to PNF compared with DGF with recovery, cortical necrosis, arterionephrosclerosis, oxalate nephropathy, and ABMR were more common. Identification of these entities on biopsy may identify patients at highest risk of graft failure.

PMID:
42602902
Bibliographic data and abstract were imported from PubMed on 15 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.